Top of this page
Skip navigation, go straight to the content
UCB - The next generation biopharma leader
UCB Worldwide
Sitemap
Search
Home
Patients
Partners
Investors
Job seekers
About UCB
Products
R & D
Media Room
Print
Contact
Sitemap
About UCB
Overview
Vision
Strategy
History
Management
Facts and figures
Company
Key strengths
Financials
Sales
Pipeline
Research & Development
Partners
CSR
Policy
Strategy
Management System
Performance score card
Programme 2010
UCB Alumni
UCB Worldwide
UCB Worldwide
Australia & New Zealand
Austria
Belgium & Luxembourg
Bulgaria
Canada
China
Czech Republic
Denmark
Egypt
Finland
France
Germany
Greece
Headquarters
Hungary
India
Ireland
Italy
Japan
Kazachstan
Korea
Mexico & Latin America
Norway
Poland
Portugal
Romania
Russia (+CIS)
Slovak Republic
Spain
Sweden
Switzerland
The Netherlands
Turkey
Ukraine
United Kingdom
U.S.A.
Investors
Overview
UCB in Brief
Company Overview
Management
R&D Pipeline
Strategy
Shares
Share Price Information
Investment Calculator
Share Price Look-up
Shareholder Structure
UCB Notifications
Major Shareholders
Capital and Shares
Warrants
Dividends
Analyst Coverage
Financials
Key Financial Data
Outlook
Debt
Convertible Bond
Eurobond
Retail Public Offering
Analyst Consensus
Annual Reports
Celltech
Schwarz Pharma
News
Presentations
Calendar
2010
Shareholders' meeting 2010
2009
Shareholders' meeting 2009
PricewaterhouseCooper
2008
Shareholders' meeting 2008
To be elected
2007
Shareholders' meeting 2007
Agenda of the General Meeting of Shareholders
Blockage of shares and authorisation
Procedure
Procedure for calling meetings
Venue and Date
2003-2006
Shareholders' meeting 2006
Shareholders' meeting 2005
Shareholders' meeting 2004
Shareholders' meeting 2003
Corporate Governance
Charter
Board of Directors
Board Committees
Executive Committee
External Audit
Articles of Association
Conduct & Ethics
Insider Trading
Compliance Program
Job Seekers
Overview
Our company
Our culture and people
IT @ UCB
About IT
A word about biopharma
IT strategy
IT life @ UCB
Summer party
Patient centricity
IT prouds
News & events
Bringing IT to Life Special Event
IT jobs
IT team
Recruitment team
Job offers
Your career
Leadership and personal development
Compensation and company benefits
Striking the right work-life balance
Traineeships
United Kingdom
Belgium
Applying to UCB
Australia
Belgium
Bulgaria
China and Hong Kong
Czech Republic
Denmark
France
Germany
Applying to UCB in Germany
Greece
Hungary
India
Ireland
Luxembourg
Mexico
Netherlands
Norway
Poland
Sweden
Switzerland
UK
US
Media Room
Overview
News
CNS press releases
Immunology press releases
Epilepsy
Epilepsy Resources
Epilepsy Fact Sheets
UCB in Epilepsy
Epilepsy Awareness Initiatives
Epilepsy Journalism Award
Background Information
Epilepsy - Personal stories
Useful Information
Epilepsy Professional Organisations
Epilepsy Patient Groups
Epilepsy Conference Dates
Key epilepsy congresses
Epilepsy Awareness Days
Rheumatoid Arthritis
Rheumatoid Arthritis resources
Rheumatoid Arthritis patient groups
Rheumatoid Arthritis professional organisations
Asthma resources
Asthma fact sheets
Asthma glossary
Asthma insights
Professor Leonardo M. Fabbri, Italy
Professor Arzu Yorgancioglu, Turkey
Professor Mina Gaga, Greece
Professor Ronald Dahl, Denmark
Asthma image library
Events & Presentations
2010
2009 full year results
2009 Half-Year Results
Pictures
Executive Commitee
Building and Infrastructure
Research
General Images
Braine
Editorial Guidelines
BioPilot Plant
Ceremony, June, 4
People
BioPilot Plant
Laboratories
Partners
Overview
Business Development
Partnering
Areas of interest
Strategic partners
Case studies
Suppliers
Biologics Plant
Suppliers' conditions
Patients
Overview
Conditions
CNS
Epilepsy
ADHD
Fibromyalgia
Memory problems
Narcolepsy
Neuropathic pain
Parkinson's disease
Restless Legs Syndrome (RLS)
Immunology
Allergies
Anaphylaxis
Crohn's disease
Osteoporosis
Respiratory disorders
Rheumatoid arthritis
Systemic lupus (SLE)
Other conditions
Bladder disorders
Coronary heart disease
Digestive disorders
Erectile dysfunction
Hypertension
Iron deficiency
Lung cancer
Non-Hodgkin's lymphoma
Peripheral arterial occlusive disease
Testimonials
Allergy
Rita Hayward's family
Crohn's disease
Barbara
Carrie
Craig
Miranda
Ally
Epilepsy
Beatriz
Bryan Griffin
Giuseppe
Heather Overton
Rachel Walz
Jerome
Lloyd
Parkinson's disease
Alun
Christer
Veronica
Wolfgang
Living with early Parkinson’s Disease
Living with late Parkinson's Disease
Rheumatoid arthritis
Alice Peterson
Clinical trials
About clinical trials
FAQ
Phase I
Phase II
Phase III
Phase IV
UCB policy
Trial information search
Trial results search
Patient Programmes
Canine Assistants programme
Live Beyond Epilepsy
UK Patient & Charitable Organisations
Support of patient organisations in Europe
2009
2008
Czech & Slovak Republics Patient Organisations
2009
2008
Links
ADHD
Allergies
Crohn's disease
Epilepsy
Narcolepsy
Rheumatoid arthritis
Products
Overview
Product list
CNS
Keppra®
Neupro®
Metadate CD™
Nootropil®
Xyrem®
Vimpat®
Immunology
Cimzia - Crohn's disease
Cimzia® - Rheumatoid arthritis
Xyzal®
Zyrtec®
Tussionex™
Lortab™
Other products
BUP-4™
Deponit®
Edex®/ Viridal®
Elantan®
Ferro Sanol®
Isoket®
Nipruss®
Perlinganit® Solution
Prostavasin®
Stogar®
Uniretic™/Femipres Plus™/Perdix Plus™
Univasc™ /Femipres™ / Perdix™
R & D
Overview
R&D pipeline
UCB's new development pipeline
Therapeutic areas
CNS
Immunology
Science & technologies
Innovative and proprietary science and technologies
UCB SLAM
Antibodies
Gene-to-drug
A2Hit™
Hit Discovery
CADD
Chromatography
SV2A
Genomics
Innovation in development
MIKADO
IP strategy
Info centre
Protein Kinase Inhibitor Chart
Drug development process
How drugs are named
NCE & NBE drug discovery overview
Facts & figures
UCB's definition of severe diseases
Clinical trials
Partnerships
People
Scientific Advisers to UCB
Prof Sir Tom Blundell
Dr Bruce Booth
Dr Francis J T Fildes
Dr Melanie Lee
Dr John M McCall
Glossary